These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 6882095)

  • 1. [Effect of intravenous disopyramide in supraventricular paroxysmal tachycardia refractory to vagal maneuvers].
    Romero-Ayala LC; Soní J
    Arch Inst Cardiol Mex; 1983; 53(2):147-51. PubMed ID: 6882095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravenously disopyramide phosphate administration for treatment of arrhythmias].
    Aquaro G; Belli R; Pavia M; Rey L; Ravera A; Possavino G; Idone P
    G Ital Cardiol; 1982; 12(7):509-19. PubMed ID: 7169147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
    Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM
    Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention and therapy of supraventricular paroxysmal tachycardia in ambulatory patients. Results of a multicentric study using disopyramide].
    Rouhi A; Penth B; Adams HJ
    Ther Ggw; 1979 Jun; 118(6):957-69. PubMed ID: 462395
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of intravenous disopyramide in the termination of supraventricular arrhythmias.
    Luoma PV; Kujala PA; Juustila HJ; Takkunen JT
    J Clin Pharmacol; 1978; 18(5-6):293-301. PubMed ID: 641217
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse reaction to disopyramide.
    Dibble JB; Webster NR
    Postgrad Med J; 1979 Sep; 55(646):570-2. PubMed ID: 514940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiarrhythmic actions of disopyramide phosphate in patients with paroxysmal supraventricular tachycardia (author's transl)].
    Satoh M; Sada T; Kuan-Min S; Kira Y; Sekine I; Okabe F; Ueda A; Ito T; Matsumoto S
    Kokyu To Junkan; 1981 May; 29(5):537-44. PubMed ID: 7313358
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of Rhytmodan in heart rhythm disorders].
    Dzieglielewski T; Wachowiak A
    Pol Tyg Lek; 1973 Dec; 28(52):2065-7. PubMed ID: 4769022
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical studies of the antiarrhythmic efficacy of disopyramide phosphate (Norpace) (author's transl)].
    Smith WS
    Herz; 1978 Dec; 63(36):399-406. PubMed ID: 95482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of intravenous disopyramide on induction and termination of paroxysmal supraventricular tachycardia via an accessory pathway].
    Komatsu C; Ishinaga T; Tateishi O; Tokuhisa Y; Hara M; Sanada T; Kanae K; Satoh Y; Yoshimura S
    Kokyu To Junkan; 1984 Apr; 32(4):409-14. PubMed ID: 6463419
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
    Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G
    Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of intravenous disopyramide phosphate on recurrent paroxysmal tachycardias.
    Camm J; Ward D; Spurrell RA
    Br J Clin Pharmacol; 1979 Nov; 8(5):441-9. PubMed ID: 508548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of antiarrhythmic effects of disopyramide by multiclinical controlled double-blind methods.
    Kimura E; Mashima S; Tanaka T
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):338-43. PubMed ID: 7409935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of intravenous disopyramide for the conversion of supraventricular tachyarrhythmias.
    Stewart DE; Ikram H
    N Z Med J; 1984 Mar; 97(751):148-50. PubMed ID: 6584758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Action of injectable disopyramide phosphate in the emergency treatment of ventricular tachycardia].
    Valère PE; Guerot C; Castillo Fenoy A; Branvin E; Urbanczyk A; Tricot R
    Coeur Med Interne; 1977; 16(2):285-92. PubMed ID: 891126
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)].
    Chiariello M; Santinelli V; Ferro G; Tari MG; Stanislao M; Condorelli M
    G Ital Cardiol; 1979; 9(9):975-83. PubMed ID: 520746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiarrhythmic effect of intravenous disopyramide in an open study.
    Tonkin AM; Heddle WF; Bett JH; Kemp RJ; Donnelly GL; Nelson GI; Manolas E; Sloman JG
    Aust N Z J Med; 1982 Aug; 12(4):271-5. PubMed ID: 6958238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electrophysiological action of disopyramide].
    Grosu AA; Malakhov VI; Smetnev AS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):51-5. PubMed ID: 7138657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of disopyramide phosphate in repetitive paroxysmal ventricular tachycardia].
    Katoh T; Sasaki Y; Tsuda T
    Kokyu To Junkan; 1982 Sep; 30(9):959-64. PubMed ID: 7178700
    [No Abstract]   [Full Text] [Related]  

  • 20. [The usefulness of adenosine triphosphate in supraventricular paroxysmal tachycardias].
    Jornet A; Palet J; Usón M; Petit M
    Rev Clin Esp; 1993 Feb; 192(2):70-2. PubMed ID: 8460236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.